Get instant access to this must see IDMP webinar series!
For several companies, the announcement of the EMA that the DADI project will be the main focus for regulatory data submissions has meant that they needed to revisit/realign their IDMP implementation projects once again. But is/was this really needed and if so, how can this be avoided going forward?
Join us to hear from the perspective of our Identification of Medicinal Products (IDMP) subject matter expert, Wim Cypers.
In this 3 part series, we will be focusing on three important aspects of an effective ISO-IDMP implementation within your organization:
- Data Management
- Process Optimization
- Cross Department Benefits